• Conexeu Sciences raised $4.75 million in a private placement that closed October 15, 2026, for working capital and general corporate purposes.
• The placement included 1,333,333 units at $3 each, comprising one common share and one common stock purchase warrant per unit.
• Another 250,000 special warrants at $3 each raised $750,000, with automatic conversion into units by February 16, 2027, or earlier.
• The common stock purchase warrants carry a $3 exercise price per share and remain exercisable for 24 months from issuance.
• Management and director subscriptions for 83,334 additional units totaling $250,002 remain in escrow pending stockholder approval; those securities have not been issued.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conexeu Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-005431), on October 20, 2026, and is solely responsible for the information contained therein.